An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC

NCT07452003 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: QL1706 plus chemotherapy

Sponsor

Peking Union Medical College Hospital